Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3NUO

Crystal Structure of HIV-1 Protease Mutant L90M with Antiviral Drug Amprenavir

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsAPS BEAMLINE 22-ID
Synchrotron siteAPS
Beamline22-ID
Temperature [K]100
Detector technologyCCD
Collection date2007-11-08
DetectorMARMOSAIC 300 mm CCD
Wavelength(s)0.8
Spacegroup nameP 21 21 2
Unit cell lengths57.940, 86.590, 46.130
Unit cell angles90.00, 90.00, 90.00
Refinement procedure
Resolution10.000 - 1.350
R-factor0.146
Rwork0.143
R-free0.19850
Structure solution methodAB INITIO PHASING
RMSD bond length0.012
RMSD bond angle0.029
Data reduction softwareHKL-2000
Data scaling softwareHKL-2000
Phasing softwareMOLREP
Refinement softwareSHELXL-97
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]50.0001.400
High resolution limit [Å]1.3501.350
Rmerge0.0550.462
Number of reflections50566
<I/σ(I)>2.5
Completeness [%]97.397.8
Redundancy3.23.1
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, HANGING DROP4.8298Crystal was grown by the hanging-drop vapor-diffusion method at room temperature, from a 3.7 mg/ml protein solution at pH 4.8 with 0.2M NaI, 0.1M NaOAc. The inhibitor was mixed with protease in a ratio 5:1 , VAPOR DIFFUSION, HANGING DROP, temperature 298K

219869

PDB entries from 2024-05-15

PDB statisticsPDBj update infoContact PDBjnumon